Latest Insider Transactions at V Tv Therapeutics Inc. (VTVT)
This section provides a real-time view of insider transactions for V Tv Therapeutics Inc. (VTVT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of vTv Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of vTv Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 18
2024
|
Paul J Sekhri Pres, CEO and Exec Chairperson |
BUY
Open market or private purchase
|
Direct |
1,844
+26.94%
|
$29,504
$16.96 P/Share
|
Nov 15
2024
|
Paul J Sekhri Pres, CEO and Exec Chairperson |
BUY
Open market or private purchase
|
Direct |
3,156
+43.02%
|
$50,496
$16.62 P/Share
|
Mar 05
2024
|
Srinivas Akkaraju |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
58,836
-22.15%
|
-
|
Mar 05
2024
|
Samsara Bio Capital Gp, LLC |
SELL
Other acquisition or disposition
|
Indirect |
58,836
-22.15%
|
-
|
Mar 05
2024
|
Baker Bros. Advisors LP |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
57,657
-37.21%
|
-
|
Feb 27
2024
|
Srinivas Akkaraju |
BUY
Grant, award, or other acquisition
|
Indirect |
224,732
+45.83%
|
$2,472,052
$11.81 P/Share
|
Nov 29
2022
|
John A Fry Director |
BUY
Open market or private purchase
|
Direct |
40,461
+39.88%
|
$0
$0.83 P/Share
|
Nov 28
2022
|
John A Fry Director |
BUY
Open market or private purchase
|
Direct |
20,539
+50.0%
|
$0
$0.83 P/Share
|
Dec 20
2021
|
Ronald O Perelman > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
87,000
-0.24%
|
$87,000
$1.15 P/Share
|
Feb 26
2021
|
Hersh Kozlov Director |
BUY
Open market or private purchase
|
Direct |
10,000
+28.57%
|
$20,000
$2.74 P/Share
|
Feb 26
2021
|
Rich S. Nelson Acting Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$20,000
$2.86 P/Share
|
Feb 26
2021
|
Rich S. Nelson Acting Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+50.0%
|
$100,000
$2.86 P/Share
|
Dec 17
2020
|
Ronald O Perelman > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
625,000
+1.68%
|
$625,000
$1.6 P/Share
|
Dec 10
2020
|
Ronald O Perelman > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
625,000
+1.71%
|
$625,000
$1.6 P/Share
|
Nov 24
2020
|
Ronald O Perelman > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
625,000
+1.74%
|
$625,000
$1.6 P/Share
|